| Hepatic Fibrosis / Hepatic Stellate Cell Activation |
0.00000 |
0.347 |
51/147 |
| Leukocyte Extravasation Signaling |
0.00000 |
0.276 |
55/199 |
| LPS/IL-1 Mediated Inhibition of RXR Function |
0.00000 |
0.247 |
54/219 |
| Propanoate Metabolism |
0.00000 |
0.190 |
23/121 |
| Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis |
0.00000 |
0.246 |
59/240 |
| LXR/RXR Activation |
0.00002 |
0.280 |
26/93 |
| Valine, Leucine and Isoleucine Degradation |
0.00002 |
0.226 |
24/106 |
| Metabolism of Xenobiotics by Cytochrome P450 |
0.00003 |
0.142 |
28/197 |
| Atherosclerosis Signaling |
0.00003 |
0.271 |
29/107 |
| Aryl Hydrocarbon Receptor Signaling |
0.00004 |
0.239 |
38/157 |
| Urea Cycle and Metabolism of Amino Groups |
0.00005 |
0.179 |
14/78 |
| Fatty Acid Metabolism |
0.00006 |
0.179 |
33/184 |
| Arginine and Proline Metabolism |
0.00006 |
0.136 |
24/177 |
| Pancreatic Adenocarcinoma Signaling |
0.00006 |
0.269 |
32/119 |
| ILK Signaling |
0.00007 |
0.238 |
46/193 |
| β-alanine Metabolism |
0.00012 |
0.194 |
18/93 |
| Glioma Invasiveness Signaling |
0.00012 |
0.333 |
20/60 |
| Colorectal Cancer Metastasis Signaling |
0.00019 |
0.218 |
56/257 |
| Inhibition of Angiogenesis by TSP1 |
0.00019 |
0.359 |
14/39 |
| Cell Cycle Control of Chromosomal Replication |
0.00021 |
0.387 |
12/31 |
| Bladder Cancer Signaling |
0.00022 |
0.283 |
26/92 |
| HIF1α Signaling |
0.00024 |
0.269 |
29/108 |
| Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes |
0.00025 |
0.265 |
27/102 |
| IL-8 Signaling |
0.00026 |
0.223 |
43/193 |
| TR/RXR Activation |
0.00068 |
0.260 |
25/96 |
